Health and Medicine

May 8, 2023

Diabetes drugs associated with fewer adverse cardiac events in older veterans: study

Vanderbilt research finds that GLP1 receptor agonists — a class of diabetes medications — are associated with fewer major adverse cardiovascular events than another type of diabetes drug (DPP4 inhibitors) in older veterans with no prior heart disease.

By Leigh MacMillan
May 8, 2023

Improved imaging for kidney disease

Vanderbilt researchers identified optimal MRI parameters for estimating the severity of polycystic kidney disease, a common inherited disorder that can lead to end-stage renal failure.

By Leigh MacMillan
May 4, 2023

Tracking lung macrophages

A new technique will allow researchers to track subsets of immune cells that patrol and defend the lungs, to better understand the roles of these cells during lung inflammation, infection and injury.

By Leigh MacMillan
May 4, 2023

Better adenoma detection

Fluorescent nanoparticles clearly identified colonic adenomas — precursors to colorectal cancer — in mice, and the formulation should translate to clinical use in humans.

By Sarah E. Glass
May 3, 2023

Vanderbilt mourns loss of former Gastroenterology director Burk

Raymond Burk Jr., MD, former director of the Vanderbilt’s Division of Gastroenterology, Hepatology and Nutrition, died May 1 in Nashville. He was 80.

By Bill Snyder
Izumi Kaji, PhD, and James Goldenring, MD, PhD, were among eight researchers from Vanderbilt University Medical Center honored last week by the American Physiological Society.
April 27, 2023

Researchers honored at American Physiology Summit

Three faculty members and five postdoctoral fellows at Vanderbilt University Medical Center received research honors last week from the American Physiological Society during its 2023 American Physiology Summit.

By Bill Snyder
April 26, 2023

Lehmann’s Vanderbilt Prize Lecture set for May 11

Vanderbilt Prize in Biomedical Science winner Ruth Lehmann, PhD, will deliver her Vanderbilt Prize Discovery Lecture at 4 p.m. Thursday, May 11, in 208 Light Hall.
By Bill Snyder
April 26, 2023

VICC Scientific Retreat focuses on emerging technologies

The Vanderbilt-Ingram Cancer Center 24th Annual Scientific Retreat will be held from 8:30 am to 3 pm, May 23, in the Vanderbilt Student Life Center.
By Tom Wilemon
April 25, 2023

COVID alters respiratory microbiota

COVID-19 infection alters the microbes of the upper respiratory tract for at least several weeks, and such disturbances could impact disease severity and be targets for therapeutic interventions.
By Leigh MacMillan
April 24, 2023

Novel drugs have potential for treating tuberculosis

Drug-resistant tuberculosis is on the rise, and novel antibacterial drugs called SPTs have potential for treating the deadly lung infection.
By Leigh MacMillan
April 20, 2023

Overactive bladder and anxiety

Anxiety and psychological stress impact hypersensitivity mechanisms in women that could contribute to overactive bladder — a frequent and sudden urge to urinate that is difficult to control.
By Sarah E. Glass
April 20, 2023

Genetics and chronic pain

Polygenic risk scores — scores that reflect the influence of common genetic variants — could be used to predict the likelihood of developing chronic overlapping pain conditions and guide biomarker and targeted prevention efforts.
By Bill Snyder
April 20, 2023

Study details RNA editing in virus-infected cancer cells

Vanderbilt researchers detail the landscape of RNA editing — a form of RNA modification — in primary effusion lymphoma cells during Kaposi’s sarcoma-associated herpesvirus infection and identify an edited viral microRNA that is critical for infection.
By Leigh MacMillan
1 … 7 8 9 10 11 … 197